Message icon
Email Address
mskccindia@icliniq.com
Phone icon
Phone Number
+91 82 700 70000
mskcc front view

Oldest & Largest Private Cancer Center

Memorial Sloan Kettering Cancer Center (MSK or MSKCC) is the world's oldest and largest private cancer center caring for cancer patients for more than 130 years. This cancer center works by keeping the patients at the center of all the work, focusing on caring and supporting the patients and their families at every instance.

The word "cancer" is terrifying, but doctors and scientists now know a lot more about this deadly illness than before, and the treatment success rate has never been better before. Nowadays, doctors are able to cure more than 50 % of individuals diagnosed with cancer, and many live long and relatively normal lives with cancer. Memorial Sloan Kettering offers you the best available treatment for your exact problem.

Cancer patients from all over the world are welcome at MSKCC. This cancer center delivers exceptional care and support by formulating treatment plans for each patient, irrespective of the treatment stage.


Committed to Exceptional Patient Care:

Committed to Exceptional Patient Care

The only focus of MSKCC's cancer specialists is to provide compassionate cancer care for each patient to achieve the best possible outcome. More than 1,300 doctors, 4,500 nurses, and 14,500 administrative support staff have been employed by MSKCC. All specialists at MSKCC are experts in their fields. The multidisciplinary Disease Management Teams develop personalized treatment plans for each patient to achieve the best possible outcome, reduce the impact of therapy, avoid unnecessary treatments, and improve the quality of life during and after treatment.

Right, and early cancer treatment often produces the best outcome. The treating physicians follow the latest treatment approaches, including immunotherapy, CAR-T cell therapy, and MSK Precise radiation therapy. The first next-generation sequencing test authorized by the FDA (US Food and Drug Administration), MSK-IMPACT, identifies genetic mutations in almost 460 genes, allowing patients to be matched to available targeted therapies or clinical trials.

Cancer treatment outcome is greatly affected by where the treatment is done. Research published recently in JAMA Oncology found that patients treated at cancer specialty hospitals have a 20 % higher survival rate one year after treatment than those treated at non-specialized hospitals in the US. This difference persisted up to five years after treatment.

Innovational Cancer Research:

State-of-the-Art Treatments and Technologies

Patients eligible for groundbreaking clinical trials can gain access to new treatment options and therapies at MSKCC, which are not available at other hospitals. The remarkable advances pioneered by MSKCC's doctors and scientists in cancer care have become the standard of care worldwide.

Leading organizations that have recognized MSKCC for exceptional cancer care:

  • MSKCC was ranked as one of the top two cancer hospitals and a leading hospital for pediatric cancer in the United States for more than 25 years by the US News & World Report.
  • MSKCC is amongst the 39 National Cancer Institute-designated Comprehensive Cancer Centers recognized for excellence in patient care, research, and education.
  • MSKCC is a Magnet hospital, which is a designation given by the American Nurses Credentialing Center in recognition of nursing excellence.
  • Being a member of the National Comprehensive Cancer Network, MSKCC sets the standards for cancer treatment and guidelines across the United States.

The joint efforts of MSKCC's doctors and scientists allow the application of research discoveries to patient care rapidly.

Multispecialty and Multidisciplinary Approach:

Multispecialty and Multidisciplinary Approach

Teamwork and joint effort ensure the best possible outcome, reduces the impact of therapy, avoids needless treatments, and improves the quality of life during and after treatment. MSKCC's Disease Management Teams, consisting of medical oncologists, surgeons, radiologists, radiation oncologists, oncology nurses, and nurse practitioners, work together to create customized treatment plans for each patient.

Advanced care can make the patient's cancer journey a little easier. Through timely administration of pain medications, fluids, and nutrition, the Enhanced Recovery after Surgery Program improves postoperative outcomes and shortens hospital stays.

Integrative medicine experts at MSKCC care for the whole person by incorporating complementary treatments, such as massage, acupuncture, meditation, and yoga, into overall treatment plants. At MSKCC, the physical and emotional side effects of cancer treatment are managed as a whole.

State-of-the-Art Treatments and Technologies:

Innovational Cancer Research

Immunotherapy studies started at MSKCC almost 100 years ago. Since then, scientists at MSKCC have invested in developing treatments that help the body's immune system destroy cancerous cells. MSKCC's groundbreaking science has changed how melanoma, leukemia, lung, bladder, and kidney cancers are treated.

MSKCC scientists have also paved the way for the use of chimeric antigen receptor (CAR) T cell therapy in the treatment of leukemia and other solid tumors. MSK is also a leader in bone marrow transplantation for people with blood disorders and cancer.

MSKCC's specialists are experts in minimally invasive, robotic, and computer-assisted surgeries.

A high degree of accuracy is achieved using advanced imaging technologies, allowing the imaging specialists to locate cancer and track responses to therapies accurately.

MSK Precise radiation therapy was developed to target breast, lung, prostate, and brain tumors with precision to reduce side effects and the number of sessions required. This leading-edge technology offers longer survival for patients with unresectable liver and pancreatic tumors.

As no two cancers are the same, MSKCC's scientists developed MSK-IMPACT. This genomic test helps identify gene mutations in any solid tumor, no matter the location in the body. This test allows patients to be matched to available targeted therapies or clinical trials that use experimental drugs. MSK-IMPACT is the first next-generation sequencing test that has been authorized by the US FDA. It identifies genetic mutations in almost 460 genes and other molecular changes in tumors.

Excellence in Research:

Excellence in Research

MSKCC's scientists and doctors work together for discoveries to move rapidly from the lab to patient care. The physicians and scientists work hard to translate groundbreaking research into better outcomes for patients.

Eligible patients are given access to therapies, surgical techniques, and advanced technologies through various clinical trials, which are not available at other hospitals. At any point in time, more than 1,000 clinical trials for adults and more than 85 clinical trials for children are on at MSKCC.

After another hospital recommended chemotherapy for breast cancer, the patient came to MSK for a second opinion. With the help of genomic testing, MSKCC doctors determined that her optimal treatment plan is a nipple-sparing mastectomy and reconstructive surgery, not chemotherapy. With the help of MSKCC's fertility preservation experts, the patient also decided to bank her eggs.